Mouse pharmacokinetic parameters of compounds 44 and 47.
Compound | i.v.a (2 mg kg−1) | p.o.b (10 mg kg−1) | ||||||
---|---|---|---|---|---|---|---|---|
AUClast (μg h mL−1) | t 1/2 (h) | CL (L h−1 kg−1) | Vss (L kg−1) | AUClast (μg h mL−1) | C max (μg mL−1) | t 1/2 (h) | F % | |
44 | 0.77 ± 0.04 | 7.05 ± 1.92 | 2.58 ± 0.15 | 1.89 ± 0.31 | 0.94 ± 0.16 | 1.54 ± 0.33 | 5.45 ± 1.48 | 24 |
47 | 0.84 ± 0.11 | 1.69 ± 1.09 | 2.39 ± 0.32 | 3.23 ± 0.81 | 4.88 ± 2.07 | 2.88 ± 1.22 | 2.30 ± 0.23 | 116 |
Dosed at 2 mg kg−1 for i. v. administration of ICR mouse (n = 3, mean ± SD) in 5% DMSO/40% PEG400/55% DW (5 mL kg−1).
Dosed at 10 mg kg−1 for p. o. administration of ICR mouse (n = 3, mean ± SD) in 5% DMSO/40% PEG400/55% DW (5 mL kg−1).